Our bacterial platforms are designed to obtain functional ingredients & finished products, guided by industry and supported by academia.
INCUBATE Accelerator program 2023
BiomeMega took part in a 14-week journey to receive intense pre-seed preparedness training. Our participation in INCUBATE (University of Sydney flagship accelerator program) expanded our knowledge and helped shape up our business.
IP protection has been crucial to propel our growth
Patents and trademarks are elaborated by our IP Advisory team at Jones-Tulloch, and allied to industry guidance both fuel our growth while ensuring our ability to discuss our technology with existing and new partners.
The University of Sydney has been our home from the start
BiomeMega was co-founded by International scientists from the prestigious School of Chemistry and Bioengineering. Dr Valtchev serves as a Scientific advisor, and Dr De Cerqueira is the visionary CEO and USyd Honorary Affiliate, running BiomeMega also as a member of the proactive Sydney Knowledge Hub.
Media recognition has also been fundamental creating awareness about our work and vision
New therapeutics are also in discussion
A new field called “Postbiotics” is currently much discussed by BigPharma, and we are starting to study the use of omega-rich probiotic membranes as cardiovascular medicines
